Table 1.
Authors | Endpoint | n | Outcome | Reference |
---|---|---|---|---|
Shima et al 1989 | Screening of impaired glucose tolerance | 302 | GA: Significantly higher values in subjects with impaired glucose tolerance FA: Values nonsignificantly different between controls and subjects with impaired glucose tolerance |
35 |
Furusyo et al 2011 | Screening of diabetes | 1575 | GA: AUC of 0.91 for screening diabetes | 36 |
Li et al 2011 | Screening of diabetes | 1480 | GA: AUC of 0.88 for screening diabetes | 37 |
Selvin et al 2011 | Prediction of diabetic complications | 1600 | GA: OR of 3.8-9.3 for diabetic complications FA: OR of 5.9-6.3 for diabetic complications |
38 |
Yang et al 2012 | Screening of diabetes | 1211 | GA: AUC of 0.86 for screening diabetes | 39 |
Malmström et al 2014 | Screening of diabetes | 10987 | FA: AUC of 0.95 for screening diabetes | 40 |
AUC, area under the curve; FA, fructosamine; GA, glycated albumin; OR, odds ratio.